WO2005072121A2 - Carrier ampholytes of high ph range - Google Patents
Carrier ampholytes of high ph range Download PDFInfo
- Publication number
- WO2005072121A2 WO2005072121A2 PCT/US2005/001061 US2005001061W WO2005072121A2 WO 2005072121 A2 WO2005072121 A2 WO 2005072121A2 US 2005001061 W US2005001061 W US 2005001061W WO 2005072121 A2 WO2005072121 A2 WO 2005072121A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- alkyl
- member selected
- groups
- alkylene
- Prior art date
Links
- 239000000959 ampholyte mixture Substances 0.000 title claims abstract description 22
- ZRALSGWEFCBTJO-UHFFFAOYSA-N guanidine group Chemical group NC(=N)N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims abstract description 20
- 238000001155 isoelectric focusing Methods 0.000 claims abstract description 11
- 125000000217 alkyl group Chemical group 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 19
- 150000001875 compounds Chemical class 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 125000002947 alkylene group Chemical group 0.000 claims description 12
- 125000003277 amino group Chemical group 0.000 claims description 10
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 10
- 150000007942 carboxylates Chemical group 0.000 claims description 7
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 8
- 238000001962 electrophoresis Methods 0.000 claims 2
- 229920000768 polyamine Polymers 0.000 abstract description 7
- 229920001281 polyalkylene Polymers 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract 1
- 239000000872 buffer Substances 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 7
- LSHROXHEILXKHM-UHFFFAOYSA-N n'-[2-[2-[2-(2-aminoethylamino)ethylamino]ethylamino]ethyl]ethane-1,2-diamine Chemical compound NCCNCCNCCNCCNCCN LSHROXHEILXKHM-UHFFFAOYSA-N 0.000 description 7
- 125000004433 nitrogen atom Chemical group N* 0.000 description 7
- 238000000926 separation method Methods 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- ZWWQRMFIZFPUAA-UHFFFAOYSA-N dimethyl 2-methylidenebutanedioate Chemical compound COC(=O)CC(=C)C(=O)OC ZWWQRMFIZFPUAA-UHFFFAOYSA-N 0.000 description 4
- 125000004181 carboxyalkyl group Chemical group 0.000 description 3
- -1 carboxyethyl groups Chemical group 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 description 2
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- RMAHPRNLQIRHIJ-UHFFFAOYSA-N methyl carbamimidate Chemical compound COC(N)=N RMAHPRNLQIRHIJ-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- FAGUFWYHJQFNRV-UHFFFAOYSA-N tetraethylenepentamine Chemical compound NCCNCCNCCNCCN FAGUFWYHJQFNRV-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- RBZRMBCLZMEYEH-UHFFFAOYSA-N 1h-pyrazol-1-ium-1-carboximidamide;chloride Chemical compound Cl.NC(=N)N1C=CC=N1 RBZRMBCLZMEYEH-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- PSZAEHPBBUYICS-UHFFFAOYSA-N 2-methylidenepropanedioic acid Chemical compound OC(=O)C(=C)C(O)=O PSZAEHPBBUYICS-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- FSDHPEVAFMYGCW-UHFFFAOYSA-O CC(C)(C)OC(NC(NC(OC(C)(C)C)=O)=[S+]C)=O Chemical compound CC(C)(C)OC(NC(NC(OC(C)(C)C)=O)=[S+]C)=O FSDHPEVAFMYGCW-UHFFFAOYSA-O 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- FBRSXDZVAJLTFZ-UHFFFAOYSA-N NN=C(C)S(=O)(=O)O Chemical compound NN=C(C)S(=O)(=O)O FBRSXDZVAJLTFZ-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 150000001912 cyanamides Chemical class 0.000 description 1
- FDKLLWKMYAMLIF-UHFFFAOYSA-N cyclopropane-1,1-dicarboxylic acid Chemical compound OC(=O)C1(C(O)=O)CC1 FDKLLWKMYAMLIF-UHFFFAOYSA-N 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920003053 polystyrene-divinylbenzene Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 238000000539 two dimensional gel electrophoresis Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44756—Apparatus specially adapted therefor
- G01N27/44795—Isoelectric focusing
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44747—Composition of gel or of carrier mixture
Definitions
- This invention resides in the field of protein separations in biochemical research, and in particular the chemical species and mixtures used as carrier ampholytes in isoelectric focusing.
- carrier ampholytes offer certain advantages over immobilized pH gradients.
- One advantage is a particularly wide range of isoelectric point variation among individual species of an ampholyte mixture.
- Another is the versatility that arises from the ability of the ampholytes to function either in the liquid phase or on a solid or semi-solid support medium such as polyacrylamide, agarose, and Sephadex. This versatility permits separations to be performed on a large scale as well as a small scale, making it convenient both for preparative separations and for use in the research laboratory.
- the pH range of any particular ampholyte mixture determines the type of separation that can be performed and the degree of resolution among solutes in the sample mixture. While the typical carrier ampholyte mixture of the prior art offers a pH range that extends well into the acid and base ranges, the typical upper end of the range is about 10.0.
- the effectiveness of ampholytes towards the outer reaches of the range is also limited by the tendency of ampholyte pH gradients to shift over time. This shift of the gradient often causes the gradient to flatten at each end, particularly at the upper end above pH 9. This limits the mixtures that can be separated effectively, and is particularly detrimental to two-dimensional electrophoresis in this range when isoelectric focusing in carrier ampholytes is used as the first dimension.
- This invention resides in novel classes of carrier ampholytes that are capable of being synthesized to have high isoelectric points, including values above 10.0, and in many cases above 12.0. While the most typical carrier ampholytes of the prior art are formed from 5 polyalkylene polyamines in which varying proportions of the nitrogen atoms have been substituted with carboxyethyl groups, the ampholytes of the present invention differ, at least in part, by the inclusion of guanidine groups in the polyalkylene polyamine backbone. [0005] A generic formula for the carrier ampholytes of the present invention is as follows:
- n integers
- X, Y, and Z represent basic groups that are combinations of amine groups and guanidine groups, substituted with carboxyalkyl groups to varying degrees.
- the total number of possible combinations depends on the length of the chain in a particular structure as determined by the value of n and hence total number of X, Y, and Z groups.
- n is greater than one, resulting in two or more Y groups on a
- Ampholyte mixtures in accordance with this invention will therefore include multiple species of Formula I varying in the number of carboxyalkyl groups bonded to the structure at its nitrogen atoms, and in some cases both the number of carboxyalkyl groups and the number of amine groups that have been replaced with guanidine groups.
- This invention thus resides in carrier ampholytes above the above formula, mixtures of ampholytes of the above formula with isoelectric points varying among the ampholytes of each mixture, and combinations of isolated ampholytes or of isolated ampholyte fractions of the above formula in which each ampholyte or fraction has a characteristic isoelectric point or range distinguishing that ampholyte or fraction from the others in the combination. Still
- this invention resides in a method for separating components of a sample, and particularly components of high isoelectric points, by isoelectric focusing in a pH gradient established by an array of carrier ampholytes of the above formula.
- the attached figure is a reaction scheme for the preparation of a certain carrier ampholytes within the scope of the present invention.
- n is 1 to 20, and when n is 2 or greater, the invention extends to structures in which the two or more Y groups are the same as well as those in which the Y groups are not all the same, i.e., one or more may differ from the others.
- a preferred range of m is 1 to 3, and a particularly preferred value is 2, in which case the group bridging the nitrogen atoms on the backbone of the structure is the ethylene group (-CH 2 CH 2 -).
- a preferred range for n is 1 to 10, a more preferred range is 1 to 6, and in particularly preferred embodiments, n is 4.
- the starting materials for the synthesis of ampholytes are the polyalkylene polyamines
- examples of polyalkylene polyamines from which ampholytes of the above description can be prepared are diethylenetriamine (DETA), triethylenetetramine (TETA), tetraethylenepentamine (TEPA), and pentaethylenehexamine (PEHA).
- Each of X, Y, and Z is either an amine group or a guanidine group such that the structure contains a combination of amine and guanidine groups, i.e., at least one group at the X, Y, or Z locations, but not all, is a guanidine group and the rest are amine groups.
- the groups covalently bonded to the amine N atoms are either H or alkyl groups, and preferred amine groups are fully alkyl-substituted, and the alkyl groups other than those joining adjacent N atoms are preferably C ⁇ - 4 alkyl groups, more preferably methyl or ethyl, and most preferably methyl groups.
- R 1 is either H, C M alkyl, C(O)OH, C(O)O-(C ]-4 alkyl), (C M alkylene)-C(O)OH, or
- R 2 is either H, CM alkyl, C(O)OH, C(O)O-(C M alkyl), (CM alkylene)-C(O)OH, or (CM alkylene)-C(O)O-(C alkyl); and R 3 is either H or C alkyl.
- carboxylate substituents of Formula II are bonded to the backbone by the reaction of the unsubstituted backbone with an ⁇ ,j3-unsaturated carboxylic acid
- examples of such acids that will result in compounds with these substituents are acrylic acid, methacrylic acid, methylene malonic acid, ethylene malonic acid, crotonic acid, maleic acid, fumaric acid, and itaconic acid.
- Combinations of these acids can also be used, to result in ampholyte molecules with two or more different carboxylate substituents or an ampholyte mixture with different carboxylate substituents on different components of the mixture.
- ampholytes of this invention are synthesized by conventional methods.
- guanidinylation agents are cyanamides, O-alkyl isoureas, aminoiminosulfonic acid, aminoiminoethane sulfonic acid, lH-pyrazole-1-carboxamidine hydrochloride, N,N'- bis(tert-butoxycarbonyl)-S-methylthiourea, and alkanesulfonyl guanidines.
- An example of a disclosure of guanidinylation reagents in the literature is Goodman, et al., United States Patent No. 6,380,358 (April 30, 2002), incorporated herein by reference.
- FIG. 1 An illustration of a reaction scheme for the preparation of the guanidine-containing ampholytes of the present invention appears in FIG. 1.
- the starting material is pentaethylene hexamine (PEHA) (A).
- PEHA pentaethylene hexamine
- B O-methyl isourea
- C one representative species
- Other species in the mixture will differ in the number of N atoms converted to guanidine groups and the location of the N atoms on the starting PEHA structure.
- the intermediates mixture is reacted with dimethyl itaconate (D) to achieve a final ampholyte mixture of which one species (E) is shown.
- D dimethyl itaconate
- E ampholyte mixture of which one species (E) is shown.
- a succinylmethyl group has become covalently bonded to only one of the N atoms that had not been converted to a guanidine group, while other species of the mixture may contain two or more succinylmethyl groups in addition to differences in the number and location of guanidine groups.
- Ampholyte mixtures in accordance w t t s nvent on can be separated into isoelectric point fractions, and can likewise aid in the separation of sample mixtures into isoelectric point solute fractions, by conventional isoelectric focusing methods.
- sample mixtures that can be separated in this manner include enzymes, hormones, antibodies, antibody fragments, polypeptides and proteins in general, as well as nucleic acids and other macromolecules and small molecules.
- the separation of sample mixtures can be achieved by first distributing the ampholytes in the suspending medium at locations corresponding to their pH, or most conveniently by first combining the ampholyte mixture and the sample mixture, placing the combined mixture in the suspending medium, and finally establishing the pH gradient with an electric potential across the medium.
- Continuous media include gels, liquids, and granules, either in columns, tubes, slab-shaped configurations, or capillaries
- discontinuous media include segmented isoelectric focusing apparatus with a different ampholyte fraction in each segment.
- the ampholyte fractions circulate through the apparatus in independent circuits while the sample solutes are free to migrate between the various segments until equilibrium is reached due to the arrival of a solute at a segment whose pH equals the isoelectric point of the solute.
- Descriptions of apparatus of this type are found in Bier, United States Patent No. 4,204,929 (May 27, 1980), Bier, United States Patent No.
- This example illustrates the synthesis of a carrier ampholyte by the guanidination of pentaethylene hexamine followed by the addition of carboxylic acid groups by reaction with dimethyl itaconate.
- en ae y ene examine . g or . mo e o ammo groups
- the pH of the resulting solution was 10.77.
- This material was passed through an anion exchange column containing approximately 600 mL of a 20-50 mesh polystyrene- divinylbenzene quaternary ammonium anion exchange resin in hydroxide form (AG 1-X8 of Bio-Rad Laboratories, Inc., Hercules, California, USA) to remove sulfate ions.
- the pH of the collected material was 13.5.
- a round-bottom flask was charged with 100 mL of this product and heated to 40°C, and dimethyl itaconate (15.6 g) was added, causing the temperature to spontaneously rise to 47°C. The temperature was then adjusted to 50°C and the reaction continued at that temperature for 22 hours. The temperature was then raised to 60°C and maintained at that level for approximately 90 hours.
- Product (112 mL) was collected and had a pH of 8.66. This was passed through a column of Bio-Rad AG 4-X4 tertiary amine resin in free base form to remove acid groups not bound to the polyamino compounds. The pH of the collected effluent was 9.1.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Electrochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Steroid Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE05705627T DE05705627T1 (en) | 2004-01-21 | 2005-01-12 | CARRIER AMPHYLENE WITH HIGH PH VALUE RANGE |
EP05705627A EP1718960B1 (en) | 2004-01-21 | 2005-01-12 | Carrier ampholytes of high ph range |
AT05705627T ATE548347T1 (en) | 2004-01-21 | 2005-01-12 | CARRIER AMPHOLYTES WITH HIGH PH RANGE |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/763,405 | 2004-01-21 | ||
US10/763,405 US7022214B2 (en) | 2004-01-21 | 2004-01-21 | Carrier ampholytes of high pH range |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005072121A2 true WO2005072121A2 (en) | 2005-08-11 |
WO2005072121A3 WO2005072121A3 (en) | 2006-04-27 |
Family
ID=34750409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/001061 WO2005072121A2 (en) | 2004-01-21 | 2005-01-12 | Carrier ampholytes of high ph range |
Country Status (5)
Country | Link |
---|---|
US (1) | US7022214B2 (en) |
EP (1) | EP1718960B1 (en) |
AT (1) | ATE548347T1 (en) |
DE (1) | DE05705627T1 (en) |
WO (1) | WO2005072121A2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013114112A3 (en) * | 2012-01-30 | 2013-11-07 | Arecor Limited | Stabilized aqueous antibody compositions |
US10209217B2 (en) | 2015-11-30 | 2019-02-19 | Intabio, Inc. | Devices and methods for sample characterization |
US10514360B1 (en) | 2018-05-31 | 2019-12-24 | Intabio, Inc. | Software for microfluidic systems interfacing with mass spectrometry |
US10591488B2 (en) | 2018-01-29 | 2020-03-17 | Intabio, Inc. | Devices, methods and kits for sample characterization |
US10870113B1 (en) | 2019-08-12 | 2020-12-22 | Intabio, Inc. | Isoelectric focusing devices and fixtures |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020142304A1 (en) * | 2001-03-09 | 2002-10-03 | Anderson Daniel G. | Uses and methods of making microarrays of polymeric biomaterials |
AU2006259415B2 (en) | 2005-06-15 | 2012-08-30 | Massachusetts Institute Of Technology | Amine-containing lipids and uses thereof |
KR101734955B1 (en) | 2008-11-07 | 2017-05-12 | 메사추세츠 인스티튜트 오브 테크놀로지 | Aminoalcohol lipidoids and uses thereof |
CN102573466A (en) | 2009-04-22 | 2012-07-11 | 墨卡托医疗系统公司 | Use of guanethidine for treating hypertension by local vascular delivery |
PT2506857T (en) | 2009-12-01 | 2018-05-14 | Translate Bio Inc | Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases |
WO2012027675A2 (en) | 2010-08-26 | 2012-03-01 | Massachusetts Institute Of Technology | Poly(beta-amino alcohols), their preparation, and uses thereof |
WO2012135025A2 (en) | 2011-03-28 | 2012-10-04 | Massachusetts Institute Of Technology | Conjugated lipomers and uses thereof |
WO2012170930A1 (en) | 2011-06-08 | 2012-12-13 | Shire Human Genetic Therapies, Inc | Lipid nanoparticle compositions and methods for mrna delivery |
CN110200963A (en) * | 2011-10-19 | 2019-09-06 | 墨卡托医疗系统公司 | Local modulation tissue and cell include kidney denervation to improve curative effect |
US20140374260A1 (en) * | 2012-02-07 | 2014-12-25 | Sharp Kabushiki Kaisha | Two-dimensional electrophoresis kit, method for manufacturing two-dimensional electrophoresis kit, two-dimensional electrophoresis method, and two-dimensional electrophoresis chip |
EP2859102A4 (en) | 2012-06-08 | 2016-05-11 | Shire Human Genetic Therapies | Nuclease resistant polynucleotides and uses thereof |
EP2882706A1 (en) | 2012-08-13 | 2015-06-17 | Massachusetts Institute of Technology | Amine-containing lipidoids and uses thereof |
NZ751462A (en) | 2013-03-14 | 2021-07-30 | Shire Human Genetic Therapies | Cftr mrna compositions and related methods and uses |
BR112015022660A2 (en) | 2013-03-14 | 2017-10-31 | Shire Human Genetic Therapies | Methods for purification of messenger rna |
US9315472B2 (en) | 2013-05-01 | 2016-04-19 | Massachusetts Institute Of Technology | 1,3,5-triazinane-2,4,6-trione derivatives and uses thereof |
EP3574923A1 (en) | 2013-10-22 | 2019-12-04 | Translate Bio, Inc. | Mrna therapy for phenylketonuria |
EP3060257B1 (en) | 2013-10-22 | 2021-02-24 | Translate Bio, Inc. | Lipid formulations for delivery of messenger rna |
EP4276176A3 (en) | 2013-10-22 | 2024-01-10 | Translate Bio, Inc. | Mrna therapy for argininosuccinate synthetase deficiency |
SG11201608725YA (en) | 2014-04-25 | 2016-11-29 | Shire Human Genetic Therapies | Methods for purification of messenger rna |
MA48050A (en) | 2014-05-30 | 2020-02-12 | Translate Bio Inc | BIODEGRADABLE LIPIDS FOR THE ADMINISTRATION OF NUCLEIC ACIDS |
KR102387898B1 (en) | 2014-06-24 | 2022-04-15 | 샤이어 휴먼 지네틱 테라피즈 인크. | Stereochemically enriched compositions for delivery of nucleic acids |
WO2016004202A1 (en) | 2014-07-02 | 2016-01-07 | Massachusetts Institute Of Technology | Polyamine-fatty acid derived lipidoids and uses thereof |
US11253605B2 (en) | 2017-02-27 | 2022-02-22 | Translate Bio, Inc. | Codon-optimized CFTR MRNA |
MX2019013752A (en) | 2017-05-16 | 2020-07-20 | Translate Bio Inc | Treatment of cystic fibrosis by delivery of codon-optimized mrna encoding cftr. |
EP3841208A1 (en) | 2018-08-24 | 2021-06-30 | Translate Bio, Inc. | Methods for purification of messenger rna |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1114155A (en) * | 1964-08-24 | 1968-05-15 | Evans Medical Ltd | Guanidino derivatives |
DE2137617C3 (en) | 1971-07-28 | 1979-01-04 | Grubhofer, Nikolaus, Dr., 6900 Heidelberg | Process for the preparation of aqueous ampholyte solutions or mixtures thereof |
DE2230743B2 (en) | 1972-06-23 | 1980-08-07 | Nikolaus Dr. 6900 Heidelberg Grubhofer | Process for the production of aqueous ampholyte solutions |
DE2656801C2 (en) | 1976-12-15 | 1983-11-17 | Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Process for the production of carrier ampholytes for the isoelectric focusing of high molecular weight amphoteric substances |
GB8713854D0 (en) | 1987-06-13 | 1987-07-15 | Kozulic B | Poly-n-acryloyl-tris(hydroxymethyl)aminomethane gels |
US5242947A (en) * | 1988-02-10 | 1993-09-07 | New York University | Use of polyamines as ionic-channel regulating agents |
US5173160A (en) | 1991-02-27 | 1992-12-22 | Board Of Regents, The University Of Texas System | Analysis of carrier ampholytes using immobilized ph gradients |
US5322906A (en) | 1991-02-27 | 1994-06-21 | Board Of Regents, The University Of Texas System | Synthesis of complex polyamines for ampholyte production |
US6072075A (en) | 1997-05-22 | 2000-06-06 | The Regents Of The University Of California | Guanidinylation reagents |
-
2004
- 2004-01-21 US US10/763,405 patent/US7022214B2/en active Active
-
2005
- 2005-01-12 DE DE05705627T patent/DE05705627T1/en active Pending
- 2005-01-12 WO PCT/US2005/001061 patent/WO2005072121A2/en active Application Filing
- 2005-01-12 EP EP05705627A patent/EP1718960B1/en not_active Not-in-force
- 2005-01-12 AT AT05705627T patent/ATE548347T1/en active
Non-Patent Citations (1)
Title |
---|
See references of EP1718960A4 * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013114112A3 (en) * | 2012-01-30 | 2013-11-07 | Arecor Limited | Stabilized aqueous antibody compositions |
US10532098B2 (en) | 2012-01-30 | 2020-01-14 | Arecor Limited | Stabilized aqueous antibody compositions |
US12016922B2 (en) | 2012-01-30 | 2024-06-25 | Arecor Limited | Stabilized aqueous antibody compositions |
US11573200B2 (en) | 2015-11-30 | 2023-02-07 | Intabio, Llc | Devices and methods for sample characterization |
US10209217B2 (en) | 2015-11-30 | 2019-02-19 | Intabio, Inc. | Devices and methods for sample characterization |
US10401324B2 (en) | 2015-11-30 | 2019-09-03 | Intabio, Inc. | Devices and methods for sample characterization |
US10782264B2 (en) | 2015-11-30 | 2020-09-22 | Intabio, Inc. | Devices and methods for sample characterization |
US10591488B2 (en) | 2018-01-29 | 2020-03-17 | Intabio, Inc. | Devices, methods and kits for sample characterization |
US10866246B2 (en) | 2018-01-29 | 2020-12-15 | Intabio, Inc. | Devices, methods and kits for sample characterization |
US10514360B1 (en) | 2018-05-31 | 2019-12-24 | Intabio, Inc. | Software for microfluidic systems interfacing with mass spectrometry |
US11285484B2 (en) | 2019-08-12 | 2022-03-29 | Intabio, Llc | Multichannel isoelectric focusing devices and high voltage power supplies |
US11224875B2 (en) | 2019-08-12 | 2022-01-18 | Intabio, Llc | Isoelectric focusing devices and fixtures |
US10870113B1 (en) | 2019-08-12 | 2020-12-22 | Intabio, Inc. | Isoelectric focusing devices and fixtures |
Also Published As
Publication number | Publication date |
---|---|
ATE548347T1 (en) | 2012-03-15 |
EP1718960A4 (en) | 2007-10-31 |
US20050155862A1 (en) | 2005-07-21 |
US7022214B2 (en) | 2006-04-04 |
EP1718960A2 (en) | 2006-11-08 |
EP1718960B1 (en) | 2012-03-07 |
DE05705627T1 (en) | 2007-05-03 |
WO2005072121A3 (en) | 2006-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1718960B1 (en) | Carrier ampholytes of high ph range | |
Langen et al. | Effect of protein application mode and acrylamide concentration on the resolution of protein spots separated by two‐dimensional gel electrophoresis | |
Sun et al. | Topography of ribosomal proteins of the Escherichia coli 30S subunit as studied with reversible cross-linking reagent methyl 4-mercaptobutyrimidate | |
US20080314751A1 (en) | Electrophoretic Separation of Analytes by Molecular Mass | |
WO1993011174A1 (en) | New formulations for polyacrylamide matrices in electrokinetic and chromatographic methodologies | |
EP0901623B1 (en) | Process for separating mixtures of substances using capillary affinity gel electrophoresis | |
WO2004014527A1 (en) | Improved methods and compositions for capillary electrophoresis (ce) | |
Pavlova et al. | SDS‐PAGE procedure: Application for characterization of new entirely uncharged nucleic acids analogs | |
Tobler et al. | Low‐molecular‐weight chiral cation exchangers: Novel chiral stationary phases and their application for enantioseparation of chiral bases by nonaqueous capillary electrochromatography | |
JP3713520B2 (en) | Coated capillary column and electrophoretic separation method as its use | |
US9925522B2 (en) | Doped materials for reverse phase chromatography | |
JP4629660B2 (en) | Production method of multimode anion exchange ligand | |
CA2825248A1 (en) | Liquid phase separation of plasmid dna isoforms and topoisomers | |
US5647987A (en) | Ion exchangers | |
US20050072674A1 (en) | Method and device for introducing a sample into an electrophoretic apparatus | |
Landers | Capillary electrophoresis: Pioneering new approaches for biomolecular analysis | |
EP1540325B1 (en) | Coated capillary electrophoresis tubes and system | |
WO2010017109A1 (en) | Systems and methods for quantitative analyte transfer | |
US9610576B2 (en) | Hydrolytically stable ion-exchange stationary phases and uses thereof | |
KR20060119633A (en) | Ph dependent ion exchange material capable of selectively binding to nucleic acids in comparison with proteins, a solid substrate having immobilized the material on the surface and a method for isolating a nucleic acid using the material and the solid substrate | |
JP2007509139A (en) | Method for synthesizing acrylamide derivatives | |
Zhang et al. | Gel electrophoretic characterization of dendritic polymers | |
JP2001505306A (en) | Electrophoretic separation method | |
US20070240991A1 (en) | Gelling Electrophoresis Loading Buffer | |
CA2486224A1 (en) | Separation process and dyes for use therewith |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005705627 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWP | Wipo information: published in national office |
Ref document number: 2005705627 Country of ref document: EP |